Sotoxen 120 Mg Tablets

Description

Sotoxen 120 mg Tablets (Sotorasib) – Targeted KRAS G12C Therapy for Lung Cancer

Sotoxen 120 mg Tablets contain Sotorasib, a targeted anticancer medicine used to treat non-small cell lung cancer (NSCLC). It belongs to a class of drugs known as KRAS G12C inhibitors, specifically designed for patients with a KRAS G12C mutation.

If you are wondering what sotorasib is used for, it is primarily prescribed for patients whose lung cancer has progressed after prior treatment, making it an important second-line therapy for NSCLC.

Sotoxen 120 mg Composition & Drug Class

• Active Ingredient: Sotorasib
• Strength: 120 mg per tablet
• Drug Class: Targeted therapy / KRAS G12C inhibitor

Sotoxen tablets fall under the precision oncology drug class, meaning they target a specific genetic mutation rather than affecting all cells.

Clinical Use & Indications of Sotoxen Tablets

Sotoxen 120 mg Indication

• Treatment of KRAS G12C-mutated NSCLC
• Used when cancer has spread or progressed after at least one therapy
• Recommended as part of sotorasib lung cancer treatment guidelines

Sotoxen 120 mg Uses in Cancer

• Sotorasib NSCLC treatment
• Sotorasib KRAS G12C mutation therapy
• Advanced or metastatic lung cancer cases

Sotorasib has shown promising results in clinical trials, demonstrating improved response rates and disease control in eligible patients.

Sotorasib Mechanism of Action (How It Works)

Sotorasib Targeted Therapy Explanation

If you’re looking for a clear sotorasib targeted therapy explanation, here’s how it works:

• KRAS G12C mutation causes uncontrolled cancer growth
• Sotorasib binds to the mutated KRAS protein
• It locks the protein in an inactive state
• This prevents cancer cells from growing and dividing

This explains how sotorasib works in lung cancer—by directly targeting the mutation responsible for tumor progression.

Sotorasib Efficacy in NSCLC

Clinical data suggests:

• Improved tumor response rates
• Slower disease progression
• Better outcomes compared to traditional chemotherapy in selected patients

This makes it a key option in sotorasib efficacy NSCLC discussions.

Dosage & Administration

Sotorasib Dosage 960 mg Daily

• Standard dose: 960 mg once daily (8 tablets of 120 mg)
• Take at the same time each day

Sotoxen 120 mg Dosage Instructions

• Can be taken with or without food
• Swallow whole or disperse in water (do not crush or chew)
• Follow your doctor’s instructions carefully

How to Take Sotoxen Tablets

• Take regularly without skipping doses
• Maintain consistency for best results

Sotorasib Dosing Schedule

• Once daily continuous dosing
• Continue until disease progression or unacceptable toxicity

Sotorasib Missed Dose Guidance

• If a dose is missed, take it as soon as possible
• Skip if close to the next dose (do not double-dose)

Sotoxen 120 mg Administration Tip

• Take 4 hours before or 10 hours after antacids

Safety & Side Effects of Sotoxen 120 mg Tablets

Sotoxen 120 mg Side Effects

Common side effects include:

• Sotorasib side effects diarrhea
• Nausea
• Fatigue
• Decreased appetite

Sotorasib Adverse Effects

Serious but less common:

• Liver toxicity
• Lung inflammation
• Severe allergic reactions

Sotorasib Liver Toxicity Management

• Regular monitoring of liver function is required
• Watch for symptoms like yellowing skin or dark urine

Sotorasib Monitoring Liver Enzymes

Doctors may perform routine blood tests to ensure safe use.

Sotoxen Tablet Safety Profile

Sotoxen is generally considered safe under medical supervision, but careful monitoring is essential.

Drug Interactions

Sotorasib may interact with:

• Hormonal contraceptives
• Certain antiviral drugs
• Other oncology medications

Always discuss all medications with your doctor to avoid sotorasib drug interactions.

Storage Instructions

• Store at room temperature
• Keep away from moisture and sunlight
• Keep out of reach of children

Why Choose Sotoxen 120 mg?

• Precision-targeted cancer therapy
• Convenient oral administration
• Proven effectiveness in KRAS G12C mutation therapy
• Suitable for advanced NSCLC patients

Conclusion

Sotoxen 120 mg Tablets (Sotorasib) represent a breakthrough in targeted lung cancer treatment, offering a personalized approach for patients with KRAS G12C mutations. With strong clinical evidence and convenient dosing, it plays a vital role in modern oncology care.

FAQs

1. What is sotorasib used for?

It is used to treat KRAS G12C-Mutant non-small cell lung cancer.

2. Is sotorasib a targeted therapy?

Yes, it is a KRAS G12C targeted therapy.

3. What is the recommended dosage?

The standard sotorasib dosage is 960 mg daily.

4. What are common side effects?

Diarrhea, nausea, fatigue, and changes in liver enzymes.

5. How effective is sotorasib?

Clinical trials show strong efficacy in patients with NSCLC and the KRAS G12C mutation.

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice. Always consult your healthcare provider before starting or changing any medication.

Reference

https://en.wikipedia.org/wiki/Sotorasib 
https://www.mayoclinic.org/drugs-supplements/sotorasib-oral-route/description/drg-20516741
https://www.fda.gov/drugs/resources-information-approved-drugs/fda-approves-sotorasib-panitumumab-kras-g12c-mutated-colorectal-cancer
https://medlineplus.gov/druginfo/meds/a621036.html